Table 1.
General characteristics of patients.
| CD group | NCD group | P | |
|---|---|---|---|
| Case, n (%) | 30 (63%) | 18 (37%) | - |
| Female sex, n (%) | 19 (67%) | 14 (78%) | 0.402 |
| Length of hospitalization (d) | 9.98 ± 6.49 | 10.95 ± 6.50 | 0.619 |
| Age at procedure (m) | 11.50 (6.75, 27.00) | 12.00 (5.75, 30.75) | 0.553 |
| Height at procedure (cm) | 74.00 ± 15.02 | 76.91 ± 21.46 | 0.583 |
| BSA(m2) | 0.40 ± 1.31 | 0.42 ± 2.44 | 0.576 |
| Cardiac function, n (%) | |||
| Normal | 22 (73%) | 10 (56%) | - |
| Mild | 6 (20%) | 5 (28%) | - |
| Moderate | 2 (7%) | 3 (17%) | - |
| Severe | 0 | 0 | - |
| Recurrent respiratory infections, n (%) | 3 (10%) | 3 (17%) | 0.822 |
| NT-proBNP (ng/dl) | 913.5 (505.5, 1,690) | 905.0 (457.3, 1,637.5) | 0.499 |
| CTR (%) | 58.41 ± 11.95 | 59.36 ± 3.16 | 0.745 |
| LVEF (%) | 70.93 ± 6.14 | 70.67 ± 6.03 | 0.884 |
| Pre-operative cardiac medications n (%) | 4 (13%) | 3 (17%) | 1.000 |
BSA, body surface area; NT-proBNP, N terminal pro B type natriuretic peptide; CTR, cardiothoracic ratio; LVEF, left ventricular ejection fraction.